Accendra Health
183 hedge funds and large institutions have $506M invested in Accendra Health in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 61 increasing their positions, 50 reducing their positions, and 30 closing their positions.
466% more call options, than puts
Call options by funds: $7.61M | Put options by funds: $1.34M
72% more capital invested
Capital invested by funds: $295M → $506M (+$211M)
22% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 50
17% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 30
2% more funds holding
Funds holding: 180 → 183 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.96% less ownership
Funds ownership: 90.72% → 87.77% (-3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$8.11M |
| 2 |
Morgan Stanley
New York
|
+$3.65M |
| 3 |
Renaissance Technologies
New York
|
+$3.25M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$2.49M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$14.7M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$6.42M |
| 3 |
PP
Prudential plc
London, England,
United Kingdom
|
-$4.06M |
| 4 |
BlackRock
New York
|
-$2.11M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$1.78M |
ACH Hedge Fund Activity: Q1 2020 in Review
183 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q1 2020, worth a combined $506M — up 72% from $295M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new ACH positions and 30 closed out — a net gain of 5 holders — while 61 added to existing stakes and 50 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $8.11M. The largest seller was JP Morgan Chase, cutting an estimated $14.7M.
- 183 institutional investors held Accendra Health (ACH) as of Q1 2020, up from 180 in Q4 2019.
- Funds reported $506M of Accendra Health stock for Q1 2020, up 72% quarter-over-quarter.
- 35 funds opened new Accendra Health positions in Q1 2020 and 30 closed out, a net change of +5 holders.
- The largest Accendra Health buyer in Q1 2020 was Goldman Sachs, an estimated $8.11M added.
- The largest Accendra Health seller in Q1 2020 was JP Morgan Chase, an estimated $14.7M sold.
Based on aggregated 13F filings for Q1 2020.